Clinical Trials Browser

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT06651697 2026-02-17

BEFORE

Phase 3 Recruiting

300 enrolled

Gynecologic

Pelvic Neoplasms

NCT07340489 2026-01-14

Serplulimab for Locally Advanced Cervical Cancer

Phase 2 Recruiting

216 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06727617 2026-01-06

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Phase 2 Recruiting

134 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04567771 2025-11-14

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Phase NA Recruiting

120 enrolled

Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Endometriosis, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

36 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT05857631 2025-04-15

PARCERII

Phase NA Recruiting

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Phase 2 Recruiting

51 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT06532539 2024-08-01

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Phase 2 Recruiting

30 enrolled

Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

NCT03534713 2023-09-21

ONCOCOL01

Phase 3 Recruiting

310 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05511623 2023-09-11

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Phase 2 Recruiting

112 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05277688 2022-09-16

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Phase 3 Recruiting

340 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03249519 2017-08-15

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer

Phase NA Recruiting

999 enrolled

Gynecologic

Hyperthermia, Uterine Cervical Neoplasms

Clinical Trials

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Detecting HPV DNA in Anal and Cervical Cancers

BEFORE

Serplulimab for Locally Advanced Cervical Cancer

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

PARCERII

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

ONCOCOL01

Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer